Advisor Partners LLC boosted its position in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 2.6% during the second quarter, Holdings Channel reports. The institutional investor owned 1,680 shares of the medical device company’s stock after buying an additional 42 shares during the period. Advisor Partners LLC’s holdings in Cooper Companies, Inc. (The) were worth $402,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in COO. YorkBridge Wealth Partners LLC raised its position in Cooper Companies, Inc. (The) by 18.5% in the first quarter. YorkBridge Wealth Partners LLC now owns 520 shares of the medical device company’s stock valued at $105,000 after buying an additional 81 shares during the period. Archford Capital Strategies LLC raised its position in Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock valued at $135,000 after buying an additional 363 shares during the period. Penserra Capital Management LLC raised its position in Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock valued at $156,000 after buying an additional 68 shares during the period. Pacer Advisors Inc. raised its position in Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock valued at $170,000 after buying an additional 31 shares during the period. Finally, Visionary Asset Management Inc. bought a new position in Cooper Companies, Inc. (The) during the second quarter valued at $201,000. 99.97% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies, Inc. (COO) opened at 242.71 on Thursday. The stock’s 50 day moving average price is $245.37 and its 200 day moving average price is $214.28. The company has a market capitalization of $11.86 billion, a P/E ratio of 36.39 and a beta of 0.61. Cooper Companies, Inc. has a 52 week low of $158.73 and a 52 week high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping the consensus estimate of $2.25 by $0.25. The firm had revenue of $522.40 million during the quarter, compared to the consensus estimate of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the business posted $2.05 earnings per share. Analysts anticipate that Cooper Companies, Inc. will post $9.63 earnings per share for the current year.

The firm also recently declared a semiannual dividend, which was paid on Monday, August 7th. Investors of record on Friday, July 21st were given a dividend of $0.03 per share. This represents a dividend yield of 0.02%. The ex-dividend date was Wednesday, July 19th. Cooper Companies, Inc. (The)’s payout ratio is 0.90%.

WARNING: This piece of content was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/10/advisor-partners-llc-purchases-42-shares-of-cooper-companies-inc-the-nysecoo.html.

Several research analysts have weighed in on the company. Oppenheimer Holdings, Inc. set a $225.00 price target on Cooper Companies, Inc. (The) and gave the stock a “hold” rating in a research report on Saturday, June 3rd. BidaskClub lowered Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Friday, August 4th. Robert W. Baird boosted their price target on Cooper Companies, Inc. (The) from $239.00 to $251.00 and gave the stock an “outperform” rating in a research report on Thursday, July 6th. J P Morgan Chase & Co reaffirmed a “neutral” rating and set a $206.00 price target (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Finally, Piper Jaffray Companies boosted their price target on Cooper Companies, Inc. (The) to $265.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 19th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $242.00.

In related news, EVP Carol R. Kaufman sold 44,092 shares of the stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $242.81, for a total transaction of $10,705,978.52. Following the completion of the sale, the executive vice president now directly owns 60,419 shares of the company’s stock, valued at $14,670,337.39. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Paul L. Remmell sold 9,294 shares of the stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $248.46, for a total value of $2,309,187.24. Following the sale, the chief executive officer now directly owns 6,186 shares of the company’s stock, valued at $1,536,973.56. The disclosure for this sale can be found here. Insiders have sold 67,331 shares of company stock valued at $16,400,454 over the last ninety days. 1.60% of the stock is currently owned by company insiders.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.